These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26277569)

  • 1. Safety of reduced anti-thrombotic strategies in HeartMate II patients: A one-year analysis of the US-TRACE Study.
    Katz JN; Adamson RM; John R; Tatooles A; Sundareswaran K; Kallel F; Farrar DJ; Jorde UP;
    J Heart Lung Transplant; 2015 Dec; 34(12):1542-8. PubMed ID: 26277569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in HeartMate II Patients With No Antiplatelet Therapy: 2-Year Results From the European TRACE Study.
    Netuka I; Litzler PY; Berchtold-Herz M; Flecher E; Zimpfer D; Damme L; Sundareswaran KS; Farrar DJ; Schmitto JD;
    Ann Thorac Surg; 2017 Apr; 103(4):1262-1268. PubMed ID: 27743637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of reduced anti-thrombotic strategy in patients with HeartMate 3 left ventricular assist device.
    Marshall D; Sanchez J; Yuzefpolskaya M; Sayer GT; Takeda K; Naka Y; Colombo PC; Uriel N; Topkara VK
    J Heart Lung Transplant; 2021 Apr; 40(4):237-240. PubMed ID: 33551226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
    Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
    J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.
    Boyle AJ; Russell SD; Teuteberg JJ; Slaughter MS; Moazami N; Pagani FD; Frazier OH; Heatley G; Farrar DJ; John R
    J Heart Lung Transplant; 2009 Sep; 28(9):881-7. PubMed ID: 19716039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
    Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is anti-platelet therapy needed in continuous flow left ventricular assist device patients? A single-centre experience.
    Litzler PY; Smail H; Barbay V; Nafeh-Bizet C; Bouchart F; Baste JM; Abriou C; Bessou JP
    Eur J Cardiothorac Surg; 2014 Jan; 45(1):55-9; discussion 59-60. PubMed ID: 23671203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin and Aspirin Versus Warfarin Alone for Prevention of Embolic Events in Patients with a HeartMate II Left Ventricular Assist Device.
    Van Tuyl JS; Hollis IB; Alburikan KA; Tran RH; Murray BP; Rodgers JE; Katz JN; Sheridan BC
    ASAIO J; 2017; 63(6):731-735. PubMed ID: 28319521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term discontinuation of antithrombotic therapy in patients with HeartMate II continuous-flow left ventricular assist device support.
    Schurr JW; Seifert FC; McLarty AJ
    Int J Artif Organs; 2019 Dec; 42(12):770-774. PubMed ID: 31298625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study.
    Maltais S; Kilic A; Nathan S; Keebler M; Emani S; Ransom J; Katz JN; Sheridan B; Brieke A; Egnaczyk G; Entwistle JW; Adamson R; Stulak J; Uriel N; O'Connell JB; Farrar DJ; Sundareswaran KS; Gregoric I;
    J Heart Lung Transplant; 2017 Jan; 36(1):1-12. PubMed ID: 27865732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation.
    Sandner SE; Riebandt J; Haberl T; Mahr S; Rajek A; Schima H; Wieselthaler GM; Laufer G; Zimpfer D
    J Heart Lung Transplant; 2014 Jan; 33(1):88-93. PubMed ID: 24239003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD.
    Stern DR; Kazam J; Edwards P; Maybaum S; Bello RA; D'Alessandro DA; Goldstein DJ
    J Card Surg; 2010 May; 25(3):352-6. PubMed ID: 20331479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.
    Uriel N; Pak SW; Jorde UP; Jude B; Susen S; Vincentelli A; Ennezat PV; Cappleman S; Naka Y; Mancini D
    J Am Coll Cardiol; 2010 Oct; 56(15):1207-13. PubMed ID: 20598466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic Strategies and Device Thrombosis.
    Gurbel PA; Shah P; Desai S; Tantry US
    Cardiol Clin; 2018 Nov; 36(4):541-550. PubMed ID: 30297071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study.
    Netuka I; Ivák P; Tučanová Z; Gregor S; Szárszoi O; Sood P; Crandall D; Rimsans J; Connors JM; Mehra MR
    J Heart Lung Transplant; 2018 May; 37(5):579-586. PubMed ID: 29655662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.